US Actress Christina Applegate Diagnosed with Multiple Sclerosis

Christina Applegate. (Getty Images)
Christina Applegate. (Getty Images)
TT
20

US Actress Christina Applegate Diagnosed with Multiple Sclerosis

Christina Applegate. (Getty Images)
Christina Applegate. (Getty Images)

Emmy-winning US actress Christina Applegate has been diagnosed with multiple sclerosis (MS), and described her condition as a "tough road".

"A few months ago I was diagnosed with MS. It's been a strange journey. But I have been so supported by people that I know who also have this condition. It's been a tough road. But as we all know, the road keeps going," she said in a tweet on Tuesday.

"As one of my friends that has MS said 'we wake up and take the indicated action.' And that's what I do. So now I ask for privacy. As I go through this thing," her tweet added.

Applegate won a Primetime Emmy for outstanding guest actress in a comedy series for "Friends" in 2003. She was nominated in the same category for the same show in 2004. She was also nominated for outstanding lead actress in a comedy series for "Samantha Who?" in 2008 and 2009.

In 2019 and 2020, Applegate was nominated in the lead actress category again for "Dead to Me", which was also nominated for outstanding comedy series.

Applegate, who first gained fame as a child actress in the hit sitcom "Married With Children", was diagnosed with breast cancer in 2008 and had a double mastectomy.



International K-Pop Fans Thrill to Prospect of BTS Reunion 

Fans of K-pop band BTS wait for photos near an ARMY Bomb during the annual 2025 BTS Festa celebrating the BTS' debut anniversary in Goyang, South Korea, Friday, June 13, 2025. (AP)
Fans of K-pop band BTS wait for photos near an ARMY Bomb during the annual 2025 BTS Festa celebrating the BTS' debut anniversary in Goyang, South Korea, Friday, June 13, 2025. (AP)
TT
20

International K-Pop Fans Thrill to Prospect of BTS Reunion 

Fans of K-pop band BTS wait for photos near an ARMY Bomb during the annual 2025 BTS Festa celebrating the BTS' debut anniversary in Goyang, South Korea, Friday, June 13, 2025. (AP)
Fans of K-pop band BTS wait for photos near an ARMY Bomb during the annual 2025 BTS Festa celebrating the BTS' debut anniversary in Goyang, South Korea, Friday, June 13, 2025. (AP)

Thousands of international fans of K-pop megastars BTS gathered on Friday in the suburbs of Seoul amid mounting excitement over an expected reunion of the group after its members complete mandatory service in the South Korean military.

This year's BTS Festa marks the 12th anniversary of the group, which last performed together in 2022 and has not toured since 2019 because of the global pandemic and subsequent military service obligations of its members.

It was unclear if any of the recently discharged performers would appear at the festival organized by the group's management agency, HYBE.

But that did not dampen the enthusiasm of fans, some of whom flew in from around the world hoping to spot some of the superstars at the gathering or at a pair of solo concerts by BTS rapper J-Hope as he wraps up his "Hope on the Stage" world tour.

"I want to enjoy everything because there are many things to do here and ... I hope to see the guys maybe," said Karla Linan Saucede, 33, who travelled from Mexico with her sister and friends.

"It's gone past excitement and into almost being numb," said Ayla O'Ryan, 45, from Scotland, adding that she planned a visit this month to practice Korean in the capital so that she could attend.

BTS' members Jimin and Jungkook discharged from the South Korean military on Wednesday, become the fifth and sixth to complete their service. Members RM and V were discharged on Tuesday and the last to finish will be Suga on June 21.

While details of a reunion have not been released, the group is expected to hold its largest ever world tour in 2026, says NH Securities, one of South Korea's largest investment firms.

Shares in HYBE jumped 11.3% in June as brokerages raised their sales estimates and target price for the agency ahead of the group's comeback.